A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.

Source:http://linkedlifedata.com/resource/pubmed/id/16949492

J. Am. Coll. Cardiol. 2006 Sep 5 48 5 992-8

Download in:

View as

Triples

General Info

PMID
16949492